These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36225597)

  • 1. Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine.
    Stefanov BA; Fussenegger M
    Front Bioeng Biotechnol; 2022; 10():986210. PubMed ID: 36225597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Bioinspired Artificial System Enabling Biomarker-Driven Therapy.
    Wang M; Zhong H; Li Y; Li J; Zhang X; He F; Wei P; Wang HH; Nie Z
    Chemistry; 2024 Aug; 30(48):e202401593. PubMed ID: 38923644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing cell-based therapies with synthetic gene circuits responsive to molecular stimuli.
    Galvan S; Teixeira AP; Fussenegger M
    Biotechnol Bioeng; 2024 Jun; ():. PubMed ID: 38867466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
    Kojima R; Aubel D; Fussenegger M
    Curr Opin Chem Biol; 2015 Oct; 28():29-38. PubMed ID: 26056952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Gene Circuits for Regulation of Next-Generation Cell-Based Therapeutics.
    Teixeira AP; Fussenegger M
    Adv Sci (Weinh); 2024 Feb; 11(8):e2309088. PubMed ID: 38126677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation.
    Price JB; Rusheen AE; Barath AS; Rojas Cabrera JM; Shin H; Chang SY; Kimble CJ; Bennet KE; Blaha CD; Lee KH; Oh Y
    Neurosurg Focus; 2020 Jul; 49(1):E6. PubMed ID: 32610297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Computational Design of Small-Molecule-Controlled Protein-Based Circuits for Synthetic Biology.
    Kretschmer S; Kortemme T
    Proc IEEE Inst Electr Electron Eng; 2022 May; 110(5):659-674. PubMed ID: 36531560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of implantable biosensors for closed-loop glucose control and other drug delivery applications.
    Scholten K; Meng E
    Int J Pharm; 2018 Jun; 544(2):319-334. PubMed ID: 29458204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Gene Circuits for Mammalian Cell-Based Applications.
    Ausländer S; Fussenegger M
    Cold Spring Harb Perspect Biol; 2016 Jul; 8(7):. PubMed ID: 27194045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic synthetic gene networks.
    Karlsson M; Weber W
    Curr Opin Biotechnol; 2012 Oct; 23(5):703-11. PubMed ID: 22305476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The engineering principles of combining a transcriptional incoherent feedforward loop with negative feedback.
    Reeves GT
    J Biol Eng; 2019; 13():62. PubMed ID: 31333758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From synthetic biology to human therapy: engineered mammalian cells.
    Scheller L; Fussenegger M
    Curr Opin Biotechnol; 2019 Aug; 58():108-116. PubMed ID: 30933864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies.
    Wang X; Zhou X; Kang L; Lai Y; Ye H
    Synth Syst Biotechnol; 2023 Sep; 8(3):416-426. PubMed ID: 37384125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
    Özdemir V; Arga KY; Aziz RK; Bayram M; Conley SN; Dandara C; Endrenyi L; Fisher E; Garvey CK; Hekim N; Kunej T; Şardaş S; Von Schomberg R; Yassin AS; Yılmaz G; Wang W
    OMICS; 2020 Feb; 24(2):62-80. PubMed ID: 32027574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases.
    Ilan Y
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013252
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.